Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Clinical trial NCT02547428 · COMPLETED
Trial details
- NCT number
- NCT02547428
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-03
- Primary completion
- 2016-06-04
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.